List of Tables
Table 1. Global Inhaler Devices for Respiratory Medicines Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Inhaler Devices for Respiratory Medicines Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Inhaler Devices for Respiratory Medicines Market Competitive Situation by Manufacturers in 2025
Table 4. Global Inhaler Devices for Respiratory Medicines Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Inhaler Devices for Respiratory Medicines Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Inhaler Devices for Respiratory Medicines Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Inhaler Devices for Respiratory Medicines Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Inhaler Devices for Respiratory Medicines, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Inhaler Devices for Respiratory Medicines, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Inhaler Devices for Respiratory Medicines, Product Types and Applications
Table 12. Global Key Manufacturers of Inhaler Devices for Respiratory Medicines, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inhaler Devices for Respiratory Medicines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Inhaler Devices for Respiratory Medicines Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inhaler Devices for Respiratory Medicines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Inhaler Devices for Respiratory Medicines Sales by Region (K Units), 2021–2026
Table 18. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Region (2021–2026)
Table 19. Global Inhaler Devices for Respiratory Medicines Sales by Region (K Units), 2027–2032
Table 20. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Region (2027–2032)
Table 21. Global Inhaler Devices for Respiratory Medicines Revenue by Region (US$ Million), 2021–2026
Table 22. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Region (2021–2026)
Table 23. Global Inhaler Devices for Respiratory Medicines Revenue by Region (US$ Million), 2027–2032
Table 24. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Region (2027–2032)
Table 25. North America Inhaler Devices for Respiratory Medicines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Inhaler Devices for Respiratory Medicines Sales by Country (K Units), 2021–2026
Table 27. North America Inhaler Devices for Respiratory Medicines Sales by Country (K Units), 2027–2032
Table 28. North America Inhaler Devices for Respiratory Medicines Revenue by Country (US$ Million), 2021–2026
Table 29. North America Inhaler Devices for Respiratory Medicines Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Inhaler Devices for Respiratory Medicines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Inhaler Devices for Respiratory Medicines Sales by Country (K Units), 2021–2026
Table 32. Europe Inhaler Devices for Respiratory Medicines Sales by Country (K Units), 2027–2032
Table 33. Europe Inhaler Devices for Respiratory Medicines Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Inhaler Devices for Respiratory Medicines Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Inhaler Devices for Respiratory Medicines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Inhaler Devices for Respiratory Medicines Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Inhaler Devices for Respiratory Medicines Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Inhaler Devices for Respiratory Medicines Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Inhaler Devices for Respiratory Medicines Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Inhaler Devices for Respiratory Medicines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Inhaler Devices for Respiratory Medicines Sales by Country (K Units), 2021–2026
Table 42. Latin America Inhaler Devices for Respiratory Medicines Sales by Country (K Units), 2027–2032
Table 43. Latin America Inhaler Devices for Respiratory Medicines Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Inhaler Devices for Respiratory Medicines Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Inhaler Devices for Respiratory Medicines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Inhaler Devices for Respiratory Medicines Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Inhaler Devices for Respiratory Medicines Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Inhaler Devices for Respiratory Medicines Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Inhaler Devices for Respiratory Medicines Revenue by Country (US$ Million), 2027–2032
Table 50. Global Inhaler Devices for Respiratory Medicines Sales (K Units) by Type (2021–2026)
Table 51. Global Inhaler Devices for Respiratory Medicines Sales (K Units) by Type (2027–2032)
Table 52. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Type (2021–2026)
Table 53. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Type (2027–2032)
Table 54. Global Inhaler Devices for Respiratory Medicines Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Inhaler Devices for Respiratory Medicines Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Type (2021–2026)
Table 57. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Type (2027–2032)
Table 58. Global Inhaler Devices for Respiratory Medicines Price (US$/Unit) by Type (2021–2026)
Table 59. Global Inhaler Devices for Respiratory Medicines Price (US$/Unit) by Type (2027–2032)
Table 60. Global Inhaler Devices for Respiratory Medicines Sales (K Units) by Application (2021–2026)
Table 61. Global Inhaler Devices for Respiratory Medicines Sales (K Units) by Application (2027–2032)
Table 62. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Application (2021–2026)
Table 63. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Application (2027–2032)
Table 64. Global Inhaler Devices for Respiratory Medicines Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Inhaler Devices for Respiratory Medicines Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Application (2021–2026)
Table 67. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Application (2027–2032)
Table 68. Global Inhaler Devices for Respiratory Medicines Price (US$/Unit) by Application (2021–2026)
Table 69. Global Inhaler Devices for Respiratory Medicines Price (US$/Unit) by Application (2027–2032)
Table 70. GlaxoSmithKline (GSK) Company Information
Table 71. GlaxoSmithKline (GSK) Description and Business Overview
Table 72. GlaxoSmithKline (GSK) Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. GlaxoSmithKline (GSK) Inhaler Devices for Respiratory Medicines Product
Table 74. GlaxoSmithKline (GSK) Recent Developments/Updates
Table 75. AstraZeneca Company Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. AstraZeneca Inhaler Devices for Respiratory Medicines Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Boehringer Ingelheim Company Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Boehringer Ingelheim Inhaler Devices for Respiratory Medicines Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Mylan Company Information
Table 86. Mylan Description and Business Overview
Table 87. Mylan Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Mylan Inhaler Devices for Respiratory Medicines Product
Table 89. Mylan Recent Developments/Updates
Table 90. Viatris Company Information
Table 91. Viatris Description and Business Overview
Table 92. Viatris Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Viatris Inhaler Devices for Respiratory Medicines Product
Table 94. Viatris Recent Developments/Updates
Table 95. Novartis Company Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Novartis Inhaler Devices for Respiratory Medicines Product
Table 99. Novartis Recent Developments/Updates
Table 100. AptarGroup Company Information
Table 101. AptarGroup Description and Business Overview
Table 102. AptarGroup Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. AptarGroup Inhaler Devices for Respiratory Medicines Product
Table 104. AptarGroup Recent Developments/Updates
Table 105. Chiesi Farmaceutici Company Information
Table 106. Chiesi Farmaceutici Description and Business Overview
Table 107. Chiesi Farmaceutici Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Chiesi Farmaceutici Inhaler Devices for Respiratory Medicines Product
Table 109. Chiesi Farmaceutici Recent Developments/Updates
Table 110. Koninklijke Philips Company Information
Table 111. Koninklijke Philips Description and Business Overview
Table 112. Koninklijke Philips Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Koninklijke Philips Inhaler Devices for Respiratory Medicines Product
Table 114. Koninklijke Philips Recent Developments/Updates
Table 115. Teva Pharmaceutical Industries Company Information
Table 116. Teva Pharmaceutical Industries Description and Business Overview
Table 117. Teva Pharmaceutical Industries Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Teva Pharmaceutical Industries Inhaler Devices for Respiratory Medicines Product
Table 119. Teva Pharmaceutical Industries Recent Developments/Updates
Table 120. Monaghan Medical Company Information
Table 121. Monaghan Medical Description and Business Overview
Table 122. Monaghan Medical Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Monaghan Medical Inhaler Devices for Respiratory Medicines Product
Table 124. Monaghan Medical Recent Developments/Updates
Table 125. OMRON Company Information
Table 126. OMRON Description and Business Overview
Table 127. OMRON Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. OMRON Inhaler Devices for Respiratory Medicines Product
Table 129. OMRON Recent Developments/Updates
Table 130. PARI International Company Information
Table 131. PARI International Description and Business Overview
Table 132. PARI International Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. PARI International Inhaler Devices for Respiratory Medicines Product
Table 134. PARI International Recent Developments/Updates
Table 135. Vectura Company Information
Table 136. Vectura Description and Business Overview
Table 137. Vectura Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Vectura Inhaler Devices for Respiratory Medicines Product
Table 139. Vectura Recent Developments/Updates
Table 140. H&T Presspart Company Information
Table 141. H&T Presspart Description and Business Overview
Table 142. H&T Presspart Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. H&T Presspart Inhaler Devices for Respiratory Medicines Product
Table 144. H&T Presspart Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Inhaler Devices for Respiratory Medicines Distributors List
Table 148. Inhaler Devices for Respiratory Medicines Customers List
Table 149. Inhaler Devices for Respiratory Medicines Market Trends
Table 150. Inhaler Devices for Respiratory Medicines Market Drivers
Table 151. Inhaler Devices for Respiratory Medicines Market Challenges
Table 152. Inhaler Devices for Respiratory Medicines Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Inhaler Devices for Respiratory Medicines
Figure 2. Global Inhaler Devices for Respiratory Medicines Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Inhaler Devices for Respiratory Medicines Market Share by Type: 2025 & 2032
Figure 4. Metered- dose Inhalers Product Picture
Figure 5. Dry-powder Inhalers Product Picture
Figure 6. Nebulizers Product Picture
Figure 7. Global Inhaler Devices for Respiratory Medicines Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Inhaler Devices for Respiratory Medicines Market Share by Application: 2025 & 2032
Figure 9. Asthma
Figure 10. Chronic Obstructive Pulmonary Disease (COPD)
Figure 11. Cystic Fibrosis (CF)
Figure 12. Idiopathic Pulmonary Fibrosis (IPF)
Figure 13. Others
Figure 14. Global Inhaler Devices for Respiratory Medicines Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Inhaler Devices for Respiratory Medicines Market Size (US$ Million), 2021–2032
Figure 16. Global Inhaler Devices for Respiratory Medicines Sales (K Units), 2021–2032
Figure 17. Global Inhaler Devices for Respiratory Medicines Average Price (US$/Unit), 2021–2032
Figure 18. Inhaler Devices for Respiratory Medicines Report Years Considered
Figure 19. Inhaler Devices for Respiratory Medicines Sales Share by Manufacturers in 2025
Figure 20. Global Inhaler Devices for Respiratory Medicines Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global Inhaler Devices for Respiratory Medicines Players: Market Share by Revenue in Inhaler Devices for Respiratory Medicines in 2025
Figure 22. Inhaler Devices for Respiratory Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global Inhaler Devices for Respiratory Medicines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America Inhaler Devices for Respiratory Medicines Sales Market Share by Country (2021–2032)
Figure 25. North America Inhaler Devices for Respiratory Medicines Revenue Market Share by Country (2021–2032)
Figure 26. United States Inhaler Devices for Respiratory Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada Inhaler Devices for Respiratory Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe Inhaler Devices for Respiratory Medicines Sales Market Share by Country (2021–2032)
Figure 29. Europe Inhaler Devices for Respiratory Medicines Revenue Market Share by Country (2021–2032)
Figure 30. Germany Inhaler Devices for Respiratory Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France Inhaler Devices for Respiratory Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. Inhaler Devices for Respiratory Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy Inhaler Devices for Respiratory Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia Inhaler Devices for Respiratory Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific Inhaler Devices for Respiratory Medicines Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific Inhaler Devices for Respiratory Medicines Revenue Market Share by Region (2021–2032)
Figure 37. China Inhaler Devices for Respiratory Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan Inhaler Devices for Respiratory Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea Inhaler Devices for Respiratory Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India Inhaler Devices for Respiratory Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia Inhaler Devices for Respiratory Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan Inhaler Devices for Respiratory Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia Inhaler Devices for Respiratory Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Inhaler Devices for Respiratory Medicines Sales Market Share by Country (2021–2032)
Figure 45. Latin America Inhaler Devices for Respiratory Medicines Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Inhaler Devices for Respiratory Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Inhaler Devices for Respiratory Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Inhaler Devices for Respiratory Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia Inhaler Devices for Respiratory Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Inhaler Devices for Respiratory Medicines Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Inhaler Devices for Respiratory Medicines Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Inhaler Devices for Respiratory Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Inhaler Devices for Respiratory Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Inhaler Devices for Respiratory Medicines Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Inhaler Devices for Respiratory Medicines by Type (2021–2032)
Figure 56. Global Revenue Market Share of Inhaler Devices for Respiratory Medicines by Type (2021–2032)
Figure 57. Global Inhaler Devices for Respiratory Medicines Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Inhaler Devices for Respiratory Medicines by Application (2021–2032)
Figure 59. Global Revenue Market Share of Inhaler Devices for Respiratory Medicines by Application (2021–2032)
Figure 60. Global Inhaler Devices for Respiratory Medicines Price (US$/Unit) by Application (2021–2032)
Figure 61. Inhaler Devices for Respiratory Medicines Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
